Diagnosed with Non-Small Cell Lung Cancer (NSCLC) and Immunotherapy not Working?
Researchers at the National Cancer Institute, National Institutes of Health are evaluating a new combination of investigational therapies to treat non-small cell lung cancer (NSCLC) in the future. Click below to join our study.
Conducted Nationwide
Previous Frontline Therapy
18+ Years Old
Travel & Lodging Provided
Diagnosed with Non-Small Cell Lung Cancer
Fast Facts
Not A Surgical Candidate
Study Background
Our researchers want to determine whether combining inhaled antibiotics and an immune checkpoint inhibitor can help non-small cell lung cancer patients who cannot have surgery.

These combined investigational treatments may help your immune system's T cells kill cancer cells. If immunotherapy has stopped working for you, you may qualify to participate in our research study.

Your participation in this study may help researchers develop treatments for advanced non-small cell lung cancer patients. Join our research study today.

PI: Chen Zhao
Additional Information